Genentech’s New NMOSD Drug Offers At-Home Treatment, Lower Cost

List price is below competitors from Alexion, Viela Bio

FDA Approved
Enspryng previously was approved in Canada, Japan and Switzerland • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip